Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia.
Saved in:
| Title: | Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia. |
|---|---|
| Authors: | Fodil, S.1 (AUTHOR), Raffoux, E.1 (AUTHOR), Dumas, P. Y.2 (AUTHOR), Desbrosses, Y.3 (AUTHOR), Larosa, F.4 (AUTHOR), Chantepie, S.5 (AUTHOR), Larcher, M. V.6 (AUTHOR), Mear, J. B.7 (AUTHOR), Peterlin, P.8 (AUTHOR), Hunault-Berger, M.9 (AUTHOR), Hospital, M. A.10 (AUTHOR), Morel, V.11 (AUTHOR), Lucas, N.12 (AUTHOR), Vidal, V.13 (AUTHOR), Salanoubat, C.14 (AUTHOR), Michel, J.15 (AUTHOR), Mediavilla, C.16 (AUTHOR), Ojeda-Uribe, M.17 (AUTHOR), Alexis, M.18 (AUTHOR), Frayfer, J.19 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Jul2021, Vol. 62 Issue 7, p1756-1760. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
